Drug Shortage Report for EPINEPHRINE INJECTION USP
Report ID | 200978 |
Drug Identification Number | 02435810 |
Brand name | EPINEPHRINE INJECTION USP |
Common or Proper name | EPINEPHRINE INJECTION USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | EPINEPHRINE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC |
Packaging size | 1mL |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-09-01 |
Actual start date | |
Estimated end date | 2024-03-25 |
Actual end date | 2024-03-27 |
Shortage status | Resolved |
Updated date | 2024-03-28 |
Company comments | Product on allocation at distributors. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-03-28 | French | Compare |
v9 | 2024-03-28 | English | Compare |
v8 | 2024-03-19 | French | Compare |
v7 | 2024-03-19 | English | Compare |
v6 | 2024-02-05 | French | Compare |
v5 | 2024-02-05 | English | Compare |
v4 | 2023-09-02 | English | Compare |
v3 | 2023-08-03 | French | Compare |
v2 | 2023-08-03 | English | Compare |
v1 | 2023-08-03 | English | Compare |
Showing 1 to 10 of 10